> A team at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute has built up a 10-gene biomarker panel for ovarian cancer that can be used to determine the aggressiveness of an individual's disease. Release
> A new report from Allied Market Research concludes that the biomarker business for diagnostics will hit $30.6 billion by 2020. The business is growing at an annual rate of 16%. Release
> Biothera says it's been building up its knowledge of a biomarker that could be used to help identify patients most likely to respond to their late-stage immunotherapy Imprime PGG, which is being studied for colorectal cancer. Release